Bruno Lucidi serves as Executive at Atea Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Bruno Lucidi has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 16, 2024 involved exercising options for 33,150 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 16, 2024 | AVIR | $0 | Option Exercise | 33,150 | $N/A | Discretionary |
Bruno Lucidi currently holds 83,150 shares of Atea Pharmaceuticals, Inc. (AVIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruno Lucidi has been a net neutral trader of AVIR stock. They have purchased $0 and sold $0 worth of shares.
Bruno Lucidi's most recent insider trade was on Jun 16, 2024, when they sold 33,150 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted